Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
AbstractBroadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccine design efforts. Developing bNAbs with increased efficacy requires understanding how antibodies interact with the native oligomannose and complex-type N-glycan shield that hides most protein epitopes on HIV-1 envelope (Env). Here we present crystal structures, including a 3.8-Å X-ray free electron laser dataset, of natively glycosylated Env trimers complexed with BG18, the most potent V3/N332gp120 glycan-targeting bNAb reported to date. Our structures show conserved contacts mediated by common D gene-encoded residues with the N332gp120 glycan and the gp120 GDIR peptide motif, but a distinct Env-binding orientation relative to PGT121/10-1074 bNAbs. BG18’s binding orientation provides additional contacts with N392gp120 and N386gp120 glycans near the V3-loop base and engages protein components of the V1-loop. The BG18-natively-glycosylated Env structures facilitate understanding of bNAb–glycan interactions critical for using V3/N332gp120 bNAbs therapeutically and targeting their epitope for immunogen design.
- Tel Aviv University Israel
- Stanford University United States
- California Institute of Technology United States
- Rockefeller University United States
- Howard Hughes Medical Institute United States
570, Glycosylation, Science, Immunology, 610, HIV Infections, CHO Cells, HIV Antibodies, HIV Envelope Protein gp120, Crystallography, X-Ray, Antibodies, Article, env Gene Products, Vaccine Related, Epitopes, Cricetulus, Protein Domains, Polysaccharides, Cricetinae, Animals, Humans, Vaccine Related (AIDS), Neutralizing, Crystallography, Biomedical and Clinical Sciences, Prevention, Q, env Gene Products, Human Immunodeficiency Virus, Biological Sciences, Antibodies, Neutralizing, Good Health and Well Being, HEK293 Cells, Medical Microbiology, X-Ray, HIV-1, HIV/AIDS, Immunization, Biochemistry and Cell Biology, Protein Multimerization, Infection, Human Immunodeficiency Virus, Protein Binding
570, Glycosylation, Science, Immunology, 610, HIV Infections, CHO Cells, HIV Antibodies, HIV Envelope Protein gp120, Crystallography, X-Ray, Antibodies, Article, env Gene Products, Vaccine Related, Epitopes, Cricetulus, Protein Domains, Polysaccharides, Cricetinae, Animals, Humans, Vaccine Related (AIDS), Neutralizing, Crystallography, Biomedical and Clinical Sciences, Prevention, Q, env Gene Products, Human Immunodeficiency Virus, Biological Sciences, Antibodies, Neutralizing, Good Health and Well Being, HEK293 Cells, Medical Microbiology, X-Ray, HIV-1, HIV/AIDS, Immunization, Biochemistry and Cell Biology, Protein Multimerization, Infection, Human Immunodeficiency Virus, Protein Binding
13 Research products, page 1 of 2
- 2017IsRelatedTo
- 2018IsRelatedTo
- 2018IsSupplementTo
- 2017IsRelatedTo
- 2018IsSupplementTo
chevron_left - 1
- 2
chevron_right
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).94 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 1% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 1%
